The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions
Abstract
PURPOSE: To evaluate the standardized uptake value (SUV) of 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) at positron emission tomography (PET) in the differentiation of benign from malignant bone lesions. MATERIALS AND METHODS: Fifty-two (19 malignant, 33 benign) primary bone lesions were examined with FDG PET prior to tissue diagnosis. The SUVs were calculated and compared between benign and malignant lesions and among histologic subgroups that included more than four cases. RESULTS: There was a statistically significant difference in SUV between benign (2.18 +/- 1.52 [SD]) and malignant (4.34 +/- 3.19) lesions in total (P =.002). However, giant cell tumors (n = 5; SUV, 4.64 +/- 1.05) showed significantly higher SUV than chondrosarcomas (n = 7; SUV, 2.23 +/- 0.74) (P =.036, adjusted for multiple comparisons) and had no statistically significant difference in SUV compared with osteosarcomas (n = 6; SUV, 3.07 +/- 0.96) (P =.171). There was no statistically significant difference in SUV between fibrous dysplasias (n = 6; SUV, 2.05 +/- 0.98) and osteosarcoma (P =.127) or chondrosarcomas (P =.667). Although the number of cases was small, three chondroblastomas, one sarcoidosis, and one Langerhans cell histiocytosis showed levels of FDG accumulation as high as that of osteosarcomas. CONCLUSION: Radiologists should be aware of the high accumulation of FDG in some benign bone lesions, especially histiocytic or giant cell-containing lesions. Consideration of histologic subtypes should be included in analysis of SUV at FDG PET of primary bone tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamacher, K., Coenen, H. H., & Stöcklin, G. (1986) · PubMed · Cited by 1,351
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
Zasadny, K. R., & Wahl, R. L. (1993) · Radiology · doi:10.1148/radiology.189.3.8234714 · Cited by 635
Cook, G. J. R., Fogelman, I., & Maisey, M. N. (1996) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(96)80006-7 · Cited by 381
Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography
Brudin, L. H., Valind, S.-O., Rhodes, C. G., Panting, C. F., Sweatmang, M., Jones, T., & Hughes, J. M. B. (1994) · European Journal of Nuclear Medicine · doi:10.1007/bf00947964 · Cited by 229
Palmer, W. E., Rosenthal, D. I., Schoenberg, O. I., Fischman, A. J., Simon, L. S., Rubin, R. H., & Polisson, R. P. (1995) · Radiology · doi:10.1148/radiology.196.3.7644624 · Cited by 224
PET in oncology: Will it replace the other modalities?
Hoh, C. K., Schiepers, C., Seltzer, M. A., Gambhir, S. S., Silverman, D. H. S., Czernin, J., Maddahi, J., & Phelps, M. E. (1997) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(97)80042-6 · Cited by 211
Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings.
Guhlmann, A., Brecht-Krauss, D., Suger, G., Glatting, G., Kotzerke, J., Kinzl, L., & Reske, S. N. (1998) · Radiology · doi:10.1148/radiology.206.3.9494496 · Cited by 210
Noninvasive grading of musculoskeletal tumors using PET.
Adler, L. P., Blair, H. F., Makley, J. T., Williams, R. P., Joyce, M., Leisure, G., Al-Kaisi, N. K., & Miraldi, F. D. (1991) · PubMed · Cited by 209
Detecting recurrent or residual lung cancer with FDG-PET
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)90602-9 · Cited by 203
Cited by
Baughman, R. P., Lower, E. E., & du Bois, R. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12888-7 · Cited by 657
(2004) · PubMed · Cited by 653
PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact
Klaeser, B., Wiskirchen, J., Wartenberg, J., Weitzel, T., Schmid, R. A., Mueller, M. D., & Krause, T. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1524-z · Cited by 68
Metadata
- Authors
- Aoki, J., Watanabe, H., Shinozaki, T., Takagishi, K., Ishijima, H., Oya, N., Sato, N., Inoue, T., & Endo, K.
- Venue
- Radiology
- Published
- 2001-06
- Volume
- 219
- Issue
- 3
- Pages
- 774-777
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2139490947
- Cited by
- 318
- References
- 18
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions. https://app.cochat.ai/papers/10.1148/radiology.219.3.r01ma08774
- The paper
- Aoki, J., Watanabe, H., Shinozaki, T., Takagishi, K., Ishijima, H., Oya, N., Sato, N., Inoue, T., & Endo, K. (2001). FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions. Radiology. https://doi.org/10.1148/radiology.219.3.r01ma08774
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.